%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%86%D8%AE%D8%A7%D8%B9_%D9%88%D8%A7%D9%84%D8%B9%D8%B5%D8%A8_%D8%A7%D9%84%D8%A8%D8%B5%D8%B1%D9%8A%D0%9E%D0%BF%D1%82%D0%B8%D0%BA%D0%BE%D0%BC%D0%B8%D0%B5%D0%BB%D0%B8%D1%82Neuromyelitis_opticaNeuromyelitis-optica-Spektrum-ErkrankungenNeuromyelitis_opticaNeuromielitis_%C3%B3ptica%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%D8%AF%D9%88%DB%8C%DA%A9Neuromy%C3%A9lite_optiqueDevicova_bolestMalattia_di_Devic%E8%A6%96%E7%A5%9E%E7%B5%8C%E8%84%8A%E9%AB%84%E7%82%8E%D0%9E%D0%BF%D1%82%D0%B8%D0%BA%D0%BE%D0%BD%D0%B5%D0%B2%D1%80%D0%BE%D0%BC%D0%B8%D0%B5%D0%BB%D0%B8%D1%82Neuromyelitis_opticaOptikusnevromyelittZesp%C3%B3%C5%82_DevicaNeuromielite_%C3%B3ptica%D0%9E%D0%BF%D1%82%D0%B8%D0%BA%D0%BE%D0%BD%D0%B5%D0%B2%D1%80%D0%BE%D0%BC%D0%B8%D0%B5%D0%BB%D0%B8%D1%82Devicova_bolestSindroma_Devic%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B9%80%E0%B8%AA%E0%B9%89%E0%B8%99%E0%B8%9B%E0%B8%A3%E0%B8%B0%E0%B8%AA%E0%B8%B2%E0%B8%97%E0%B8%95%E0%B8%B2%E0%B8%81%E0%B8%B1%E0%B8%9A%E0%B9%84%E0%B8%82%E0%B8%AA%E0%B8%B1%E0%B8%99%E0%B8%AB%E0%B8%A5%E0%B8%B1%E0%B8%87%E0%B8%AD%E0%B8%B1%E0%B8%81%E0%B9%80%E0%B8%AA%E0%B8%9AQ611458
about
Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20Biobank For MS And Other Demyelinating DiseasesMaintenance Plasma Exchange for Neuromyelitis OpticaSafety and Tolerability of Rituximab in Neuromyelitis OpticaPediatric NMOSD Observational StudyClinic Registry Study of Optic Neuromyelitis Spectrum Disease in ChinaA Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSDSafety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis OpticaAutologous Hematopoietic Stem Cell Transplant in Neuromyelitis OpticaScrambler Trial for Pain in NMOSDA Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum DisordersAutologous Transplant To End NMO Spectrum DisorderFrench Registry for Monitoring Pregnancies for Multiple SclerosisA Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersOptic Neuritis Differential Diagnosis StudyC1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica ExacerbationEvaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution OctEfficacy and Safety Study as Monotherapy of Satralizumab (SA237) to Treat NMO and NMOSDEfficacy and Safety Study as Add-on Therapy of Satralizumab (SA237) to Treat NMO and NMOSDPilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica RelapsesEfficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersAn Open Label Extension Trial of Eculizumab in Relapsing NMO PatientsA Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse MyelitisTreatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 BUblituximab for Acute Neuromyelitis Optica (NMO) RelapsesAutologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum DisordersThe Longitudinal CONQUER Study of Rare Neuroimmunologic DisordersAn Open Label Study of the Effects of Eculizumab in Neuromyelitis OpticaHematopoietic Stem Cell Transplant in Devic's DiseaseTocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum DisordersClinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University HospitalSafety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisolonePEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.Central Pain Study for ABX-1431Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD PatientsEfficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum DisorderThe French Multiple Sclerosis Registry
P1050
Neuromyelitis optica pathogenesis and aquaporin 4Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesTh17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic ImplicationsInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersChallenges and opportunities in designing clinical trials for neuromyelitis opticaMolecular pathogenesis of neuromyelitis opticaA treatment of neuromyelitis optica (Devic's disease) during pregnancyOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderNeuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.NMO-IgG: a specific biomarker for neuromyelitis optica.Experimental models of neuromyelitis optica.Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literatureUpdate on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Demographic and clinical features of neuromyelitis optica: A review.HCV-related central and peripheral nervous system demyelinating disorders.The Gut Microbiome in Neuromyelitis Optica.Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.Mechanisms for lesion localization in neuromyelitis optica spectrum disorders.Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.Altered neurovascular coupling in neuromyelitis opticaMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica
P921
Q61907326-75772EC8-4FE7-43F1-A953-44ED9A63075BQ61924626-45343C5C-24DC-42F4-8CD8-F8E8E9C935CAQ61957689-286DDAD7-A79F-4836-A24D-17CFF4CED740Q61980311-97A4EF50-FF5A-4ACC-AC45-EE9C27EE35D7Q62031723-E2FBE2AA-096C-4A4F-85E3-530A5EBBC08EQ62818912-A338CA9A-C14F-40B8-8380-4EB292908D5BQ63229766-57E6CF11-0F84-4337-8482-EF7727F43B4CQ63334223-F767E05F-F682-4279-974B-58897342738FQ63335063-5353B66F-5EED-4467-B58B-3903FBB57013Q63400725-60D6C66E-9D39-4446-8524-43C29C6586AAQ63533860-E5DEBEF6-F91B-4CDB-BF95-424A195AEC4EQ63578435-4B66EA75-8055-4568-8414-C2CCD5E2861EQ63579028-95A2F012-4D0E-46BE-B6F2-A06D6189308AQ63590663-48019F91-5024-4ABB-BCB6-160352F6D135Q63811823-3F2ECE74-66FE-4CF0-BABC-A3BA954EA374Q63837206-C2D9023D-7B94-44EC-87C8-EAC28250D765Q63839528-1F6E0805-FB30-443B-BA87-9697F588389DQ64172372-C4052895-92AC-4F6C-A78B-8DCD7D9C5C77Q64183630-94FBD83D-5731-43D0-96C8-264C05218AD3Q64221296-979F662D-F835-4B92-A7CF-8929F04B61B4Q64350242-286FE087-3DCA-4ACD-83D5-0121DA2AF08AQ64351760-4FC75FBB-4109-4270-959C-8F79720B63C2Q64394992-B3CF70DF-38BA-40EE-A74F-B39F2DB96BD6Q64599635-7146A65B-04D1-4CC3-A80A-1A398CE4A089Q64600566-0BCBD72C-8292-4B58-ABD6-78810B83BE77Q64602514-82E84FEB-8BFA-4F42-8250-B35E308E2371Q64644499-A6236E74-AC6E-4D9D-B726-43F3AB0CD003Q64675839-D231BE07-8EF8-4A0A-A239-D3974A7116ECQ64710161-ECD90C45-38B3-4762-937A-F5A65BF15430Q64788747-4AF4791A-BE6D-442E-8640-26AD22793647Q64794160-DEB14238-4CA8-4014-929D-047EDE126652Q65355112-A3D9BB60-2EFD-43A6-B57F-2A149A3F5276Q65365831-E0CA9685-4A6F-42EC-995C-D3DD19B4F1F2Q65474917-96D249CC-2F23-4AD2-9C85-6D55395511A7Q66060742-092C83E0-1340-40B0-B5D8-49DA6D6A0721Q66067202-A11B162D-3E21-41AB-AD7C-ED0BF0FD7C04Q66071141-2A6FBA17-5A05-42D2-BA6D-0A0CA4A7C368Q66077074-719D1B6D-CAEA-4425-96A5-5061630A5387Q66083341-96D9D93A-EFEA-4C9F-A86D-012F75C07D75Q66083811-C59379A9-7A94-4556-97BB-0F5006F20D5F
P1050
Q21245240-755A12B0-4984-49DA-8F88-460552DB3784Q26748229-A494B4B2-C235-4A10-8ED7-66C2AF95996AQ26767391-748E0113-D664-4D4A-A193-26EB9B8CD8FBQ26768649-4A7288BD-24BE-4DEB-87B3-2495C7B6736DQ26824579-F5372D8E-D8CC-4D2B-A6CE-F9A2830385D8Q26999708-DFEF33FC-08F6-4528-9BA3-7ED8B5CD73B4Q27021535-DE4D9F5B-A947-4F8B-A08F-D626569C1D7DQ28067384-7186F581-ADEE-4BA6-BC0D-E321C2248678Q28076588-A342BDD7-F507-40BA-B9E1-06926DAA6F19Q30649660-DA551C66-9A26-4CAB-A01A-1B947B686258Q31080010-A41EE5C5-72CE-4BC4-9451-88974B0BE219Q33785380-177BF998-65F6-410D-839A-06E226A6BFF8Q34320394-71320EFC-4C82-44F1-B644-A29BE88DDCE9Q35052199-18D95807-1B01-45DE-913B-24AF1580BED9Q35718428-FE42D29F-E558-4740-92EA-1BA9D47C9149Q38246873-A33AA027-853F-4933-AE21-53DE13AD00C8Q47252742-6FF8F4AA-5E8E-45B7-BF0D-373AD1A080D5Q47548881-AFE3B9A9-0201-49CD-83F3-7EDD068C230CQ49713173-FED9AFE0-0C12-4FB7-B35B-FAD1612C103AQ55258910-66CACE58-A4AE-4BF7-BEA1-38BB9F6B3E72Q57391800-417D0190-06B7-4FDB-814E-EF7E446D7AC3Q59800435-9D99B3A8-79C3-46F0-997B-DEE50073E275Q63335063-9544A993-230D-4C26-9BF4-F8F4B1E21368
P921
description
Krankheit
@de
grave e rara forma di malattia ...... vo ottico e il midollo spinale
@it
inflammatory demyelinating dis ...... ic neuritis and acute myelitis
@en
مرض من الأمراض
@ar
name
Devicova bolest
@hr
Devicova bolest
@sh
Neuromielitis óptica
@es
Neuromyelitis optica
@de
Neuromyelitis optica
@nl
Neuromyelitis optica
@zh
Neuromyélite optique
@fr
Sindroma Devic
@sq
Zespół Devica
@pl
malattia di Devic
@it
type
label
Devicova bolest
@hr
Devicova bolest
@sh
Neuromielitis óptica
@es
Neuromyelitis optica
@de
Neuromyelitis optica
@nl
Neuromyelitis optica
@zh
Neuromyélite optique
@fr
Sindroma Devic
@sq
Zespół Devica
@pl
malattia di Devic
@it
altLabel
Devic disease
@en
Devic syndrome
@en
Devic's disease
@en
Devic's neuromyelitis optica
@en
Devic's syndrome
@en
Devics sjukdom
@nn
Devics syndrom
@nn
Morbus Devic
@cs
NMO spectrum disorder
@en
NMO
@en
prefLabel
Devicova bolest
@hr
Devicova bolest
@sh
Neuromielitis óptica
@es
Neuromyelitis optica
@de
Neuromyelitis optica
@nl
Neuromyelitis optica
@zh
Neuromyélite optique
@fr
Sindroma Devic
@sq
Zespół Devica
@pl
malattia di Devic
@it
P279
P2888
P672
P486
P6366
P646
P672
P1193
P1325
P138
P1550
P1692
P1748
P1995
P279
P2892
P3417
Neuromyelitis-Optica